{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:04:07Z","timestamp":1792119847017,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.pharmthera.2005.06.021","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T11:38:16Z","timestamp":1123846696000},"page":"3-17","source":"Crossref","is-referenced-by-count":162,"title":["Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences"],"prefix":"10.1016","volume":"108","author":[{"given":"Nora D.","family":"Volkow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib1","first-page":"67","article-title":"Ability of baclofen in reducing alcohol craving and intake: II. Preliminary clinical evidence","volume":"24","author":"Addolorato","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","article-title":"HIV and hepatitis C coinfection within the CAESAR study","volume":"5","author":"Amin","year":"2004","journal-title":"HIV Med"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib2","series-title":"Treatment Matching in Alcoholism. International Research Monographs in the Addictions Series","year":"2002"},{"issue":"7","key":"10.1016\/j.pharmthera.2005.06.021_bib4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00213-003-1758-6","article-title":"Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats","volume":"174","author":"Belluzzi","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib6","first-page":"312","article-title":"Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates","volume":"46","author":"Benveniste","year":"2005","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2005.06.021_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/alcalc\/37.5.478","article-title":"A potential role for GABA(B) agonists in the treatment of psychostimulant addiction","volume":"37","author":"Brebner","year":"2002","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00213-004-1968-6","article-title":"Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates","volume":"177","author":"Brebner","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0896-6273(00)80374-8","article-title":"Acute effects of cocaine on human brain activity and emotion","volume":"19","author":"Breiter","year":"1997","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/syn.10278","article-title":"Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA","volume":"50","author":"Brodie","year":"2003","journal-title":"Synapse"},{"issue":"13","key":"10.1016\/j.pharmthera.2005.06.021_bib11","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.03-0073rev","article-title":"Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis","volume":"17","author":"Cadet","year":"2003","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0376-8716(01)00185-5","article-title":"Sex differences in the effects of baclofen on the acquisition of intravenous cocaine self-administration in rats","volume":"66","author":"Campbell","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.pharmthera.2005.06.021_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.pharmthera.2005.06.021_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.58.8.755","article-title":"Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement","volume":"58","author":"Carroll","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"47","key":"10.1016\/j.pharmthera.2005.06.021_bib15","first-page":"1106","article-title":"Diagnoses of HIV\/AIDS-32 states, 2000\u20132003","volume":"53","year":"2004","journal-title":"MMWR Weekly"},{"issue":"50","key":"10.1016\/j.pharmthera.2005.06.021_bib16","first-page":"1178","article-title":"Alcohol consumption among women who are pregnant or who might become pregnant","volume":"53","year":"2004","journal-title":"MMWR Weekly"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib17","series-title":"AIDS Surveillance\u2014General Epidemiology L178 Slide Series (slide 9)","year":"2005"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib18","series-title":"HIV Prevention Strategic Plan Through 2005","year":"2005"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib19","series-title":"Targeting Tobacco Use: The Nation's Leading Cause of Death","year":"2005"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pscychresns.2004.06.004","article-title":"Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure","volume":"132","author":"Chang","year":"2004","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuroscience.2004.05.021","article-title":"Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine","volume":"127","author":"Chefer","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0892-0362(03)00017-5","article-title":"The effects of prenatal cocaine exposure on reversal learning using a simple visual discrimination task in rhesus monkeys","volume":"25","author":"Chelonis","year":"2003","journal-title":"Neurotoxicol Teratol"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archpsyc.56.6.493","article-title":"Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study","volume":"56","author":"Crits-Christoph","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study","volume":"70","author":"Dackis","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajmg.c.30013","article-title":"An analysis of the effects of prenatal alcohol exposure on growth: a teratologic model","volume":"127","author":"Day","year":"2004","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2005.06.021_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-4328(02)00286-3","article-title":"Nucleus accumbens shell and core dopamine: differential role in behavior and addiction","volume":"137","author":"Di Chiara","year":"2002","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","article-title":"Neuroimaging and neuropathological studies of depression: implications for the cognitive\u2013emotional features of mood disorders","volume":"11","author":"Drevets","year":"2001","journal-title":"Curr Opin Neurobiol"},{"issue":"11","key":"10.1016\/j.pharmthera.2005.06.021_bib28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpedi.158.11.1043","article-title":"Preventing substance use and disordered eating: initial outcomes of the ATHENA (athletes targeting healthy exercise and nutrition alternatives) program","volume":"158","author":"Elliot","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v22n01_03","article-title":"Why extensive participation in treatment and twelve-step programs is associated with the cessation of addictive behaviors: an application of the addicted-self model of recovery","volume":"22","author":"Fiorentine","year":"2003","journal-title":"J Addict Dis"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2004.10.001","article-title":"Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder","volume":"5","author":"Fone","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-3223(01)01269-0","article-title":"Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients","volume":"51","author":"Franklin","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2005.06.021_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib33","series-title":"Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector","author":"Fulco","year":"1995"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7861\/clinmedicine.5-1-69","article-title":"Drug misuse: a review of treatments","volume":"5","author":"Gerada","year":"2005","journal-title":"Clin Med"},{"issue":"21","key":"10.1016\/j.pharmthera.2005.06.021_bib35","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1073\/pnas.0402680101","article-title":"Dynamic mapping of human cortical development during childhood through early adulthood","volume":"101","author":"Gogtay","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.pharmthera.2005.06.021_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.276.19.1555","article-title":"Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program","volume":"276","author":"Goldberg","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/comp.2002.33500","article-title":"The relationship between anxiety and substance use disorders among individuals with severe affective disorders","volume":"43","author":"Goodwin","year":"2002","journal-title":"Compr Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","article-title":"The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991\u20131992 and 2001\u20132002","volume":"74","author":"Grant","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0899-3289(01)00096-7","article-title":"Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up","volume":"13","author":"Grant","year":"2001","journal-title":"J Subst Abuse"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib40","series-title":"Alternative Pharmacotherapies for Opiate Addiction","author":"Greenstein","year":"1997"},{"issue":"9","key":"10.1016\/j.pharmthera.2005.06.021_bib41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1469-8749.1993.tb11731.x","article-title":"Visual evoked potentials and visual processing in stimulant drug-exposed infants","volume":"35","author":"Hansen","year":"1993","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2005.06.021_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropharm.2004.06.004","article-title":"The methamphetamine experience: a NIDA partnership","volume":"47","author":"Hanson","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib43","series-title":"Report prepared by The Lewin Group for the National Institute on Alcohol Abuse and Alcoholism","article-title":"Updating estimates of the economic costs of alcohol abuse in the United States: Estimates, update methods, and data","author":"Harwood","year":"2000"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib44","unstructured":"Harwood, H. (2004). The Economic Costs of Drug Abuse in the United States: 1992\u20132002. Report prepared by The Lewin Group for the Office of National Drug Control Policy (ONDCP)."},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.150.4.675b","article-title":"Disulfiram therapy in patients abusing cocaine and alcohol","volume":"150","author":"Higgins","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0306-4603(02)00297-6","article-title":"Voucher-based incentives. A substance abuse treatment innovation","volume":"27","author":"Higgins","year":"2002","journal-title":"Addict Behav"},{"issue":"5712","key":"10.1016\/j.pharmthera.2005.06.021_bib47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1126\/science.1105436","article-title":"Whole-genome patterns of common DNA variation in three human populations","volume":"307","author":"Hinds","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmthera.2005.06.021_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.npp.1300654","article-title":"Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons","volume":"30","author":"Hu","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2005.06.021_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0379-0738(02)00160-3","article-title":"Drug abuse's smallest victims: in utero drug exposure","volume":"128","author":"Huestis","year":"2002","journal-title":"Forensic Sci Int"},{"issue":"8","key":"10.1016\/j.pharmthera.2005.06.021_bib50","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1073\/pnas.0409888102","article-title":"CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5455","key":"10.1016\/j.pharmthera.2005.06.021_bib51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.287.5455.1056","article-title":"Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome","volume":"287","author":"Ikonomidou","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib52","series-title":"Monitoring the Future. National Results on Adolescent Drug Use: Overview of Key Findings, 2004","author":"Johnston","year":"2005"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coph.2003.11.002","article-title":"Glutamate systems in cocaine addiction","volume":"4","author":"Kalivas","year":"2004","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2005.06.021_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11920-004-0021-0","article-title":"Recent understanding in the mechanisms of addiction","volume":"6","author":"Kalivas","year":"2004","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"10.1016\/j.pharmthera.2005.06.021_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2005.02.005","article-title":"Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission","volume":"45","author":"Kalivas","year":"2005","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1196\/annals.1308.003","article-title":"Risk taking and novelty seeking in adolescence: introduction to part I","volume":"1021","author":"Kelley","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.pharmthera.2005.06.021_bib58","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archpsyc.57.10.953","article-title":"Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis","volume":"57","author":"Kendler","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib59","series-title":"The Cochrane Database of Systematic Reviews","article-title":"Naltrexone maintenance treatment for opioid dependence","author":"Kirchmayer","year":"2003"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1077801295001001004","article-title":"Sexual abuse during childhood and adolescence as predictors of HIV-related sexual risk during adulthood among female sexual partners of injection drug users","volume":"1","author":"Klein","year":"1995","journal-title":"Violence Against Women"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.1999.tb07876.x","article-title":"Stress, corticotropin-releasing factor, and drug addiction","volume":"897","author":"Koob","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/NMM:5:1:085","article-title":"Genes associated with addiction: alcoholism, opiate, and cocaine addiction","volume":"5","author":"Kreek","year":"2004","journal-title":"Neuromol Med"},{"issue":"20","key":"10.1016\/j.pharmthera.2005.06.021_bib63","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: a population-based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib64","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2005.06.021_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.devbrainres.2003.09.001","article-title":"Consequences of prenatal cocaine exposure in nonhuman primates","volume":"147","author":"Lidow","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2005.06.021_bib66","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4065\/79.8.1031","article-title":"Taking the physician out of \u201cphysician shopping\u201d: a case series of clinical problems associated with Internet purchases of medication","volume":"79","author":"Lineberry","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1076\/jcen.23.1.121.1223","article-title":"The role of functional neuroimaging in the neuropsychology of depression","volume":"23","author":"Liotti","year":"2001","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/14728214.10.2.323","article-title":"Development of medications for alcohol use disorders: Recent advances and ongoing challenges","volume":"10","author":"Litten","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nn1383","article-title":"Central amygdala ERK signaling pathway is critical to incubation of cocaine craving","volume":"8","author":"Lu","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1196\/annals.1308.035","article-title":"The emergence of collaborative brain function: FMRI studies of the development of response inhibition","volume":"1021","author":"Luna","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molbrainres.2004.05.014","article-title":"DeltaFosB: a molecular switch for long-term adaptation in the brain","volume":"132","author":"McClung","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2005.06.021_bib71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.annepidem.2003.10.001","article-title":"Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection","volume":"14","author":"McCoy","year":"2004","journal-title":"Ann Epidemiol"},{"issue":"8","key":"10.1016\/j.pharmthera.2005.06.021_bib72","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"J Neurosci"},{"issue":"13","key":"10.1016\/j.pharmthera.2005.06.021_bib73","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1360-0443.2005.01012.x","article-title":"Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring","volume":"100","author":"McLellan","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nn798","article-title":"Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration","volume":"5","author":"Morgan","year":"2002","journal-title":"Nat Neurosci"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2005.06.021_bib77","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/00126334-200210012-00006","article-title":"Molecular basis for interactions of HIV and drugs of abuse","volume":"31","author":"Nath","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2005.06.021_bib79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2004.06.031","article-title":"Molecular mechanisms of drug addiction","volume":"47","author":"Nestler","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib80","series-title":"NIH Publication No. 00-4180","article-title":"Principles of drug addiction treatment: A research based guide","year":"2000"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib81","series-title":"NIH Publication No. 03-4212(B)","article-title":"Preventing drug abuse among children and adolescents","year":"2003"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0892-0362(02)00232-5","article-title":"Growth from birth onwards of children prenatally exposed to drugs: a literature review","volume":"24","author":"Nordstrom-Klee","year":"2002","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/13556210410001717006","article-title":"Fetal alcohol syndrome at the cellular level","volume":"9","author":"Olney","year":"2004","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib84","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.physbeh.2004.02.008","article-title":"Opioids and alcoholism","volume":"81","author":"Oswald","year":"2004","journal-title":"Physiol Behav"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib85","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States\u2014an analysis of cost-effectiveness","volume":"352","author":"Paltiel","year":"2005","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2005.06.021_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(99)00071-X","article-title":"A comprehensive guide to the application of contingency management procedures in clinical settings","volume":"58","author":"Petry","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0740-5472(94)00080-B","article-title":"An intensive outpatient approach for cocaine abuse treatment. The Matrix model","volume":"12","author":"Rawson","year":"1995","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v21n01_09","article-title":"Status of methamphetamine users 2\u20135 years after outpatient treatment","volume":"21","author":"Rawson","year":"2002","journal-title":"J Addict Dis"},{"issue":"19","key":"10.1016\/j.pharmthera.2005.06.021_bib89","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.264.19.2511","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.pharmthera.2005.06.021_bib90","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.278.10.823","article-title":"Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health","volume":"278","author":"Resnick","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib91","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0892-0362(96)00121-3","article-title":"Prenatal cocaine exposure: effects on the development of school-age children","volume":"18","author":"Richardson","year":"1996","journal-title":"Neurotoxicol Teratol"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib92","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2004-832942","article-title":"Alcohol and hepatitis C","volume":"24","author":"Safdar","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib75","series-title":"SAMHSA\/CSAT Treatment Improvement Protocol (TIP) 35: Enhancing Motivation for Change in Substance Abuse Treatment","year":"1999"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib93","series-title":"Drug and Alcohol Services Information System (DASIS) Report: Pregnant Women in Substance Abuse Treatment: 2002","year":"2004"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib94","series-title":"Results from the 2003 National Survey on Drug Use and Health (NSDUH Series H-25)","year":"2004"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib95","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMsa042657","article-title":"Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy","volume":"352","author":"Sanders","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-003-1446-6","article-title":"Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine","volume":"168","author":"Schiffer","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1360-0443.1992.tb01936.x","article-title":"Drug abuse research and HIV\/AIDS: a national perspective from the US","volume":"87","author":"Schuster","year":"1992","journal-title":"Br J Addict"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib98","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1749-6632.1997.tb51972.x","article-title":"Social stress, depression, and brain dopamine in female cynomolgus monkeys","volume":"807","author":"Shively","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.pharmthera.2005.06.021_bib99","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4088\/JCP.v64n1207","article-title":"Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use","volume":"64","author":"Shoptaw","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"20","key":"10.1016\/j.pharmthera.2005.06.021_bib100","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.291.20.2448","article-title":"Cognitive outcomes of preschool children with prenatal cocaine exposure","volume":"291","author":"Singer","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib101","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1212\/WNL.57.2.255","article-title":"Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero","volume":"57","author":"Smith","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib102","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1006\/nimg.2002.1328","article-title":"Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure","volume":"17","author":"Sowell","year":"2002","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib103","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1073858404263960","article-title":"Mapping changes in the human cortex throughout the span of life","volume":"10","author":"Sowell","year":"2004","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"10.1016\/j.pharmthera.2005.06.021_bib105","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1176\/ajp.155.8.1009","article-title":"Nicotine-induced limbic cortical activation in the human brain: a functional MRI study","volume":"155","author":"Stein","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.neuron.2004.07.019","article-title":"Homer proteins regulate sensitivity to cocaine","volume":"43","author":"Szumlinski","year":"2004","journal-title":"Neuron"},{"issue":"5698","key":"10.1016\/j.pharmthera.2005.06.021_bib107","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1099420","article-title":"Nicotine activation of alpha4 receptors: sufficient for reward, tolerance, and sensitization","volume":"306","author":"Tapper","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0376-8716(95)01175-6","article-title":"The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse","volume":"39","author":"Tarter","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"26","key":"10.1016\/j.pharmthera.2005.06.021_bib109","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1523\/JNEUROSCI.0713-04.2004","article-title":"Structural abnormalities in the brains of human subjects who use methamphetamine","volume":"24","author":"Thompson","year":"2004","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.pharmthera.2005.06.021_bib110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archpsyc.56.7.655","article-title":"Common genetic vulnerability for nicotine and alcohol dependence in men","volume":"56","author":"True","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"9468","key":"10.1016\/j.pharmthera.2005.06.021_bib111","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib126","article-title":"Estimated pregnancy rates for the United States, 1990\u20132000: An Update","volume":"52 (23)","author":"Ventura","year":"2004"},{"issue":"10","key":"10.1016\/j.pharmthera.2005.06.021_bib112","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2004.07.007","article-title":"The reality of comorbidity: depression and drug abuse","volume":"56","author":"Volkow","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890140210","article-title":"Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers","volume":"14","author":"Volkow","year":"1993","journal-title":"Synapse"},{"issue":"6627","key":"10.1016\/j.pharmthera.2005.06.021_bib114","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2005.06.021_bib115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/nlme.2002.4099","article-title":"Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies","volume":"78","author":"Volkow","year":"2002","journal-title":"Neurobiol Learn Mem"},{"issue":"10","key":"10.1016\/j.pharmthera.2005.06.021_bib116","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: insights from imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib117","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mp.4001507","article-title":"Dopamine in drug abuse and addiction: results from imaging studies and treatment implications","volume":"9","author":"Volkow","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2005.06.021_bib118","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0024-3205(98)00619-5","article-title":"Regional brain metabolic activation during craving elicited by recall of previous drug experiences","volume":"64","author":"Wang","year":"1999","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib119","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.06.021_bib120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0024-3205(03)00260-1","article-title":"Heart disease, methamphetamine and AIDS","volume":"73","author":"Yu","year":"2003","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.pharmthera.2005.06.021_bib121","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/syn.10198","article-title":"Differential gene expression in the rat caudate putamen after \u201cbinge\u201d cocaine administration: advantage of triplicate microarray analysis","volume":"48","author":"Yuferov","year":"2003","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.021_bib122","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1046\/j.1471-4159.2002.01089.x","article-title":"The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression","volume":"82","author":"Zhang","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.06.021_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300680","article-title":"Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.021_bib124","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","article-title":"Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway","volume":"165","author":"Zhu","year":"2000","journal-title":"J Immunol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T17:49:48Z","timestamp":1552585788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805001439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0163725805001439"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.06.021","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}